Bulletin
Investor Alert

Harrow Health Inc.

NAS: HROW

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 26, 2023, 7:59 p.m.

/zigman2/quotes/206805265/composite

$

21.00

Change

+0.89 +4.43%

Volume

Volume 27

Quotes are delayed by 20 min

/zigman2/quotes/206805265/composite

Previous close

$ 21.12

$ 20.11

Change

-1.01 -4.78%

Day low

Day high

$19.85

$21.61

Open

52 week low

52 week high

$6.00

$28.25

Open
Sorry, there are no transactions available for this individual.

Officers and Executives

Mr. Mark L. Baum
Chairman & Chief Executive Officer
Mr. Andrew R. Boll
Chief Financial Officer & Secretary
Mr. Kim K.J Barratt
Chief Talent Officer
Dr. Dennis E. Saadeh
Chief Formulation Strategy
Mr. John P. Saharek
Chief Commercial Officer
Dr. Richard L. Lindstrom
Director
Mr. Jamie Webb
Director-Communication & Investors Relation
Dr. Mark Mannebach
Head-Regulatory Affairs & Pharmacovigilance
Ms. Teresa F. Sparks
Independent Director
Dr. R. Lawrence van Horn
Lead Independent Director
Mr. Perry J. Sternberg
Independent Director
Dr. Marty Makary
Independent Director
Link to MarketWatch's Slice.